Financhill
Sell
30

MGRO.V Quote, Financials, Valuation and Earnings

Last price:
$0.66
Seasonality move :
-23.29%
Day range:
$0.66 - $0.73
52-week range:
$0.50 - $1.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.60x
P/B ratio:
13.35x
Volume:
125.6K
Avg. volume:
116.3K
1-year change:
-50.38%
Market cap:
$38.8M
Revenue:
$398K
EPS (TTM):
-$0.12

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MGRO.V
MustGrow Biologics Corp.
$5M -$0.02 4108.75% -14.89% --
CS.TO
Capstone Copper Corp.
$475.8M $0.16 -30.36% 87.77% $17.47
FM.TO
First Quantum Minerals Ltd.
$999.5M $0.05 20.33% -38.42% $22.37
III.TO
Imperial Metals Corp.
-- -- -- -- --
KRN.TO
Karnalyte Resources, Inc.
-- -- -- -- --
LUN.TO
Lundin Mining Corp.
$867.8M $0.22 -36.31% -18.13% $18.43
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MGRO.V
MustGrow Biologics Corp.
$0.66 -- $38.8M -- $0.00 0% 4.60x
CS.TO
Capstone Copper Corp.
$16.03 $17.47 $12.2B 28.53x $0.00 0% 4.12x
FM.TO
First Quantum Minerals Ltd.
$38.73 $22.37 $32.3B 502.33x $0.08 0% 4.60x
III.TO
Imperial Metals Corp.
$11.56 -- $2.1B 10.47x $0.00 0% 2.95x
KRN.TO
Karnalyte Resources, Inc.
$0.18 -- $9.3M -- $0.00 0% --
LUN.TO
Lundin Mining Corp.
$34.62 $18.43 $29.7B 755.90x $0.03 0.5% 6.50x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MGRO.V
MustGrow Biologics Corp.
16.71% -1.462 1.53% 1.15x
CS.TO
Capstone Copper Corp.
31.04% 3.422 21.68% 0.70x
FM.TO
First Quantum Minerals Ltd.
38.13% 2.180 36.48% 0.72x
III.TO
Imperial Metals Corp.
19.68% 0.606 23.17% 0.38x
KRN.TO
Karnalyte Resources, Inc.
-- -7.113 -- 1.34x
LUN.TO
Lundin Mining Corp.
9.6% 2.698 4.71% 0.79x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MGRO.V
MustGrow Biologics Corp.
$167.2K -$2.4M -189.39% -357.53% -306.87% -$314.1K
CS.TO
Capstone Copper Corp.
$176M $153.3M 6.75% 9.51% 18.6% -$29.7M
FM.TO
First Quantum Minerals Ltd.
$477.9M $433.9M 0.1% 0.17% 23.4% $1.1B
III.TO
Imperial Metals Corp.
$69.7M $65M 15.38% 21.06% 38.52% $31.7M
KRN.TO
Karnalyte Resources, Inc.
-$18K -$319K -22.71% -22.71% -- -$448K
LUN.TO
Lundin Mining Corp.
$401.4M $381.2M 4.26% 5.26% 28.74% $138.3M

MustGrow Biologics Corp. vs. Competitors

  • Which has Higher Returns MGRO.V or CS.TO?

    Capstone Copper Corp. has a net margin of -307.84% compared to MustGrow Biologics Corp.'s net margin of 43.86%. MustGrow Biologics Corp.'s return on equity of -357.53% beat Capstone Copper Corp.'s return on equity of 9.51%.

    Company Gross Margin Earnings Per Share Invested Capital
    MGRO.V
    MustGrow Biologics Corp.
    21.19% -$0.04 $3.5M
    CS.TO
    Capstone Copper Corp.
    21.36% $0.45 $7.3B
  • What do Analysts Say About MGRO.V or CS.TO?

    MustGrow Biologics Corp. has a consensus price target of --, signalling upside risk potential of 748.49%. On the other hand Capstone Copper Corp. has an analysts' consensus of $17.47 which suggests that it could grow by 8.97%. Given that MustGrow Biologics Corp. has higher upside potential than Capstone Copper Corp., analysts believe MustGrow Biologics Corp. is more attractive than Capstone Copper Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MGRO.V
    MustGrow Biologics Corp.
    0 1 0
    CS.TO
    Capstone Copper Corp.
    11 1 0
  • Is MGRO.V or CS.TO More Risky?

    MustGrow Biologics Corp. has a beta of 0.803, which suggesting that the stock is 19.681% less volatile than S&P 500. In comparison Capstone Copper Corp. has a beta of 2.272, suggesting its more volatile than the S&P 500 by 127.225%.

  • Which is a Better Dividend Stock MGRO.V or CS.TO?

    MustGrow Biologics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Capstone Copper Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MustGrow Biologics Corp. pays -- of its earnings as a dividend. Capstone Copper Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MGRO.V or CS.TO?

    MustGrow Biologics Corp. quarterly revenues are $789.2K, which are smaller than Capstone Copper Corp. quarterly revenues of $824.2M. MustGrow Biologics Corp.'s net income of -$2.4M is lower than Capstone Copper Corp.'s net income of $361.5M. Notably, MustGrow Biologics Corp.'s price-to-earnings ratio is -- while Capstone Copper Corp.'s PE ratio is 28.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MustGrow Biologics Corp. is 4.60x versus 4.12x for Capstone Copper Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MGRO.V
    MustGrow Biologics Corp.
    4.60x -- $789.2K -$2.4M
    CS.TO
    Capstone Copper Corp.
    4.12x 28.53x $824.2M $361.5M
  • Which has Higher Returns MGRO.V or FM.TO?

    First Quantum Minerals Ltd. has a net margin of -307.84% compared to MustGrow Biologics Corp.'s net margin of -5.8%. MustGrow Biologics Corp.'s return on equity of -357.53% beat First Quantum Minerals Ltd.'s return on equity of 0.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    MGRO.V
    MustGrow Biologics Corp.
    21.19% -$0.04 $3.5M
    FM.TO
    First Quantum Minerals Ltd.
    25.78% -$0.08 $25.9B
  • What do Analysts Say About MGRO.V or FM.TO?

    MustGrow Biologics Corp. has a consensus price target of --, signalling upside risk potential of 748.49%. On the other hand First Quantum Minerals Ltd. has an analysts' consensus of $22.37 which suggests that it could fall by -42.24%. Given that MustGrow Biologics Corp. has higher upside potential than First Quantum Minerals Ltd., analysts believe MustGrow Biologics Corp. is more attractive than First Quantum Minerals Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    MGRO.V
    MustGrow Biologics Corp.
    0 1 0
    FM.TO
    First Quantum Minerals Ltd.
    7 10 0
  • Is MGRO.V or FM.TO More Risky?

    MustGrow Biologics Corp. has a beta of 0.803, which suggesting that the stock is 19.681% less volatile than S&P 500. In comparison First Quantum Minerals Ltd. has a beta of 1.860, suggesting its more volatile than the S&P 500 by 86.031%.

  • Which is a Better Dividend Stock MGRO.V or FM.TO?

    MustGrow Biologics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Quantum Minerals Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.08 per share. MustGrow Biologics Corp. pays -- of its earnings as a dividend. First Quantum Minerals Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MGRO.V or FM.TO?

    MustGrow Biologics Corp. quarterly revenues are $789.2K, which are smaller than First Quantum Minerals Ltd. quarterly revenues of $1.9B. MustGrow Biologics Corp.'s net income of -$2.4M is higher than First Quantum Minerals Ltd.'s net income of -$107.4M. Notably, MustGrow Biologics Corp.'s price-to-earnings ratio is -- while First Quantum Minerals Ltd.'s PE ratio is 502.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MustGrow Biologics Corp. is 4.60x versus 4.60x for First Quantum Minerals Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MGRO.V
    MustGrow Biologics Corp.
    4.60x -- $789.2K -$2.4M
    FM.TO
    First Quantum Minerals Ltd.
    4.60x 502.33x $1.9B -$107.4M
  • Which has Higher Returns MGRO.V or III.TO?

    Imperial Metals Corp. has a net margin of -307.84% compared to MustGrow Biologics Corp.'s net margin of 22.84%. MustGrow Biologics Corp.'s return on equity of -357.53% beat Imperial Metals Corp.'s return on equity of 21.06%.

    Company Gross Margin Earnings Per Share Invested Capital
    MGRO.V
    MustGrow Biologics Corp.
    21.19% -$0.04 $3.5M
    III.TO
    Imperial Metals Corp.
    41.32% $0.22 $1.2B
  • What do Analysts Say About MGRO.V or III.TO?

    MustGrow Biologics Corp. has a consensus price target of --, signalling upside risk potential of 748.49%. On the other hand Imperial Metals Corp. has an analysts' consensus of -- which suggests that it could fall by -19.98%. Given that MustGrow Biologics Corp. has higher upside potential than Imperial Metals Corp., analysts believe MustGrow Biologics Corp. is more attractive than Imperial Metals Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MGRO.V
    MustGrow Biologics Corp.
    0 1 0
    III.TO
    Imperial Metals Corp.
    0 0 0
  • Is MGRO.V or III.TO More Risky?

    MustGrow Biologics Corp. has a beta of 0.803, which suggesting that the stock is 19.681% less volatile than S&P 500. In comparison Imperial Metals Corp. has a beta of 0.745, suggesting its less volatile than the S&P 500 by 25.463%.

  • Which is a Better Dividend Stock MGRO.V or III.TO?

    MustGrow Biologics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Imperial Metals Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MustGrow Biologics Corp. pays -- of its earnings as a dividend. Imperial Metals Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MGRO.V or III.TO?

    MustGrow Biologics Corp. quarterly revenues are $789.2K, which are smaller than Imperial Metals Corp. quarterly revenues of $168.8M. MustGrow Biologics Corp.'s net income of -$2.4M is lower than Imperial Metals Corp.'s net income of $38.5M. Notably, MustGrow Biologics Corp.'s price-to-earnings ratio is -- while Imperial Metals Corp.'s PE ratio is 10.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MustGrow Biologics Corp. is 4.60x versus 2.95x for Imperial Metals Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MGRO.V
    MustGrow Biologics Corp.
    4.60x -- $789.2K -$2.4M
    III.TO
    Imperial Metals Corp.
    2.95x 10.47x $168.8M $38.5M
  • Which has Higher Returns MGRO.V or KRN.TO?

    Karnalyte Resources, Inc. has a net margin of -307.84% compared to MustGrow Biologics Corp.'s net margin of --. MustGrow Biologics Corp.'s return on equity of -357.53% beat Karnalyte Resources, Inc.'s return on equity of -22.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    MGRO.V
    MustGrow Biologics Corp.
    21.19% -$0.04 $3.5M
    KRN.TO
    Karnalyte Resources, Inc.
    -- -$0.01 $4M
  • What do Analysts Say About MGRO.V or KRN.TO?

    MustGrow Biologics Corp. has a consensus price target of --, signalling upside risk potential of 748.49%. On the other hand Karnalyte Resources, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that MustGrow Biologics Corp. has higher upside potential than Karnalyte Resources, Inc., analysts believe MustGrow Biologics Corp. is more attractive than Karnalyte Resources, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MGRO.V
    MustGrow Biologics Corp.
    0 1 0
    KRN.TO
    Karnalyte Resources, Inc.
    0 0 0
  • Is MGRO.V or KRN.TO More Risky?

    MustGrow Biologics Corp. has a beta of 0.803, which suggesting that the stock is 19.681% less volatile than S&P 500. In comparison Karnalyte Resources, Inc. has a beta of 0.990, suggesting its less volatile than the S&P 500 by 1.036%.

  • Which is a Better Dividend Stock MGRO.V or KRN.TO?

    MustGrow Biologics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Karnalyte Resources, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MustGrow Biologics Corp. pays -- of its earnings as a dividend. Karnalyte Resources, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MGRO.V or KRN.TO?

    MustGrow Biologics Corp. quarterly revenues are $789.2K, which are larger than Karnalyte Resources, Inc. quarterly revenues of --. MustGrow Biologics Corp.'s net income of -$2.4M is lower than Karnalyte Resources, Inc.'s net income of -$509K. Notably, MustGrow Biologics Corp.'s price-to-earnings ratio is -- while Karnalyte Resources, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MustGrow Biologics Corp. is 4.60x versus -- for Karnalyte Resources, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MGRO.V
    MustGrow Biologics Corp.
    4.60x -- $789.2K -$2.4M
    KRN.TO
    Karnalyte Resources, Inc.
    -- -- -- -$509K
  • Which has Higher Returns MGRO.V or LUN.TO?

    Lundin Mining Corp. has a net margin of -307.84% compared to MustGrow Biologics Corp.'s net margin of 19.16%. MustGrow Biologics Corp.'s return on equity of -357.53% beat Lundin Mining Corp.'s return on equity of 5.26%.

    Company Gross Margin Earnings Per Share Invested Capital
    MGRO.V
    MustGrow Biologics Corp.
    21.19% -$0.04 $3.5M
    LUN.TO
    Lundin Mining Corp.
    30.25% $0.26 $10.7B
  • What do Analysts Say About MGRO.V or LUN.TO?

    MustGrow Biologics Corp. has a consensus price target of --, signalling upside risk potential of 748.49%. On the other hand Lundin Mining Corp. has an analysts' consensus of $18.43 which suggests that it could fall by -46.77%. Given that MustGrow Biologics Corp. has higher upside potential than Lundin Mining Corp., analysts believe MustGrow Biologics Corp. is more attractive than Lundin Mining Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MGRO.V
    MustGrow Biologics Corp.
    0 1 0
    LUN.TO
    Lundin Mining Corp.
    8 9 0
  • Is MGRO.V or LUN.TO More Risky?

    MustGrow Biologics Corp. has a beta of 0.803, which suggesting that the stock is 19.681% less volatile than S&P 500. In comparison Lundin Mining Corp. has a beta of 1.692, suggesting its more volatile than the S&P 500 by 69.211%.

  • Which is a Better Dividend Stock MGRO.V or LUN.TO?

    MustGrow Biologics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lundin Mining Corp. offers a yield of 0.5% to investors and pays a quarterly dividend of $0.03 per share. MustGrow Biologics Corp. pays -- of its earnings as a dividend. Lundin Mining Corp. pays out -132.05% of its earnings as a dividend.

  • Which has Better Financial Ratios MGRO.V or LUN.TO?

    MustGrow Biologics Corp. quarterly revenues are $789.2K, which are smaller than Lundin Mining Corp. quarterly revenues of $1.3B. MustGrow Biologics Corp.'s net income of -$2.4M is lower than Lundin Mining Corp.'s net income of $254.3M. Notably, MustGrow Biologics Corp.'s price-to-earnings ratio is -- while Lundin Mining Corp.'s PE ratio is 755.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MustGrow Biologics Corp. is 4.60x versus 6.50x for Lundin Mining Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MGRO.V
    MustGrow Biologics Corp.
    4.60x -- $789.2K -$2.4M
    LUN.TO
    Lundin Mining Corp.
    6.50x 755.90x $1.3B $254.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Buy
67
PRLB alert for Feb 10

Proto Labs, Inc. [PRLB] is down 2.16% over the past day.

Sell
30
MSTR alert for Feb 10

Strategy, Inc. [MSTR] is up 2.59% over the past day.

Sell
10
MOH alert for Feb 10

Molina Healthcare, Inc. [MOH] is down 3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock